We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$2.86B
AUM Growth
+$344M
Cap. Flow
+$315M
Cap. Flow %
11.01%
Top 10 Hldgs %
23.55%
Holding
1,809
New
745
Increased
318
Reduced
227
Closed
516

Sector Composition

Rank Sector Weight
1 Utilities 15.61%
2 Technology 12.98%
3 Industrials 12.91%
4 Consumer Discretionary 9.54%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TISI icon
1101
Team
TISI
$105M
$211K 0.01%
1,168
+168
+17% +$27.8K
AKRX
1102
DELISTED
Akorn Inc
AKRX
$211K 0.01%
55,444
+29,328
+112% +$105K
NBHC icon
1103
National Bank Holdings
NBHC
$1.86B
$210K 0.01%
6,131
+32
+0.5% +$1.11K
WIX icon
1104
WIX.com
WIX
$3.53B
$210K 0.01%
1,800
-6,600
-79% -$918K
BL icon
1105
BlackLine
BL
$1.86B
$209K 0.01%
4,380
+409
+10% +$20.4K
BIG
1106
DELISTED
Big Lots, Inc.
BIG
$209K 0.01%
8,532
-20,469
-71% -$487K
HLIT icon
1107
Harmonic Inc
HLIT
$1.31B
$208K 0.01%
+31,625
New +$219K
NOMD icon
1108
Nomad Foods
NOMD
$1.69B
$208K 0.01%
+10,159
New +$217K
SMTC icon
1109
Semtech
SMTC
$11.3B
$208K 0.01%
+4,288
New +$204K
GTHX
1110
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$208K 0.01%
+9,147
New +$288K
AVTA
1111
DELISTED
Avantax, Inc. Common Stock
AVTA
$208K 0.01%
9,598
-2,370
-20% -$59.8K
AL
1112
DELISTED
Air Lease Corp
AL
$207K 0.01%
+4,960
New +$204K
COUP
1113
DELISTED
Coupa Software Incorporated
COUP
$207K 0.01%
1,600
-16,901
-91% -$2.34M
ANF icon
1114
Abercrombie & Fitch
ANF
$4.99B
$206K 0.01%
+13,200
New +$220K
SM icon
1115
SM Energy
SM
$8.67B
$206K 0.01%
+21,300
New +$217K
CROX icon
1116
Crocs
CROX
$6.03B
$205K 0.01%
+7,400
New +$179K
ALX
1117
Alexander's
ALX
$1.38B
$204K 0.01%
+586
New +$215K
QLYS icon
1118
Qualys
QLYS
$6.17B
$204K 0.01%
2,700
-2,700
-50% -$225K
PTCT icon
1119
PTC Therapeutics
PTCT
$5.93B
$203K 0.01%
+6,000
New +$261K
WEX icon
1120
WEX
WEX
$6.93B
$203K 0.01%
+1,005
New +$208K
CF icon
1121
CF Industries
CF
$19.6B
$202K 0.01%
4,100
-6,806
-62% -$330K
NGVT icon
1122
Ingevity
NGVT
$2.37B
$202K 0.01%
+2,384
New +$212K
OTTR icon
1123
Otter Tail
OTTR
$3.86B
$202K 0.01%
+3,759
New +$197K
CHGG icon
1124
Chegg
CHGG
$88.9M
$201K 0.01%
+6,700
New +$266K
PCH
1125
DELISTED
PotlatchDeltic
PCH
$201K 0.01%
+4,900
New +$190K

Similar funds

Michael Gelband's Q3 2019 Portfolio in Review

As of Q3 2019, Michael Gelband held 1,809 positions worth $2.86B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Michael Gelband deployed $315M of net new capital in Q3 2019, opening 745 new positions and adding to 318 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.

By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $41.1M trimmed.

  • Michael Gelband's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
  • Michael Gelband added most to Aramark in Q3 2019, an estimated $65.8M increase.
  • Michael Gelband's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $41.1M.
  • Michael Gelband fully exited Altaba Inc in Q3 2019, selling an estimated $68.3M.
  • Michael Gelband's ten largest holdings make up 24% of its $2.86B portfolio in Q3 2019.
  • Michael Gelband opened 745 new positions and closed 516 in Q3 2019.
  • Michael Gelband's portfolio value rose 14% quarter-over-quarter to $2.86B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.